Quotient Limited Banner Image

Quotient Limited

  • Ticker QTNT
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Quotient Limited Logo Image
  • 201-500 Employees
  • Based in Eysins, Switzerland
Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalitiesMore. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. A serological test was developed in April 2020 in response to the global COVID-19 pandemic. The MosaiQ COVID-19 Antibody Microarray is CE marked and is the subject of an Emergency Use Authorization issued by the U.S. Food and Drug Administration. The COVID-19 antibody test is available for distribution in the U.S., the EU, the UK and Switzerland. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania.
4.8 / 5.0 (226)

Quotient Limited reports have an aggregate usefulness score of 4.8 based on 226 reviews.

Quotient Limited

Most Recent Annual Report

Quotient Limited
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Quotient Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!